Cardiac Resynchronization Therapy Devices Market in Europe to Grow at a CAGR of 8.09% over the Period 2015-2019: MarketResearchReports.biz
According to WHO, cardiovascular diseases accounted for more than half of all deaths in the European region. The annual overall cost of cardiovascular diseases in the top five European countries is estimated to be $90.10 billion, of which 54% is attributed to healthcare costs, 24% to loss in productivity, and 22% to informal care.
View full press release